Prudential Financial’s Immunovant IMVT Stock Holding History

Prudential Financial’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$545K	Buy	14,150 +1,350	+11%	+$41.1K	﹤0.01%	1875
2026 Q1	$318K	Buy	+12,800	New	+$331K	﹤0.01%	2009
2024 Q2	–	Sell	-35,349	Closed	-$1.14M	–	2742
2024 Q1	$1.14M	Sell	35,349 -25,381	-42%	-$926K	﹤0.01%	1750
2023 Q4	$2.56M	Buy	60,730 +35,890	+144%	+$1.32M	﹤0.01%	1284
2023 Q3	$954K	Sell	24,840 -48,400	-66%	-$1.09M	﹤0.01%	1790
2023 Q2	$1.39M	Sell	73,240 -50,390	-41%	-$940K	﹤0.01%	1633
2023 Q1	$1.92M	Buy	123,630 +6,900	+6%	+$120K	﹤0.01%	1368
2022 Q4	$2.07M	Buy	116,730 +350	+0.3%	+$4.41K	﹤0.01%	1290
2022 Q3	$650K	Buy	+116,380	New	+$569K	﹤0.01%	1953
2021 Q2	–	Sell	-18,114	Closed	-$290K	–	2591
2021 Q1	$290K	Buy	18,114 +13,436	+287%	+$354K	﹤0.01%	2282
2020 Q4	$217K	Buy	+4,678	New	+$216K	﹤0.01%	2338

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Prudential Financial's IMVT Position: Q2 2026 in Review

Prudential Financial increased its Immunovant (IMVT) stake by 11% in Q2 2026, buying an estimated $41.1K and bringing the position to 14,150 shares worth $545K. The position accounts for ﹤0.01% of the portfolio, ranked #1875.

Prudential Financial first reported a position in IMVT in Q4 2020 and has held it in 11 quarters since. The position peaked at $2.56M in Q4 2023. 227 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

Prudential Financial held 14,150 shares of Immunovant worth $545K as of Q2 2026.
Prudential Financial bought 1,350 Immunovant shares in Q2 2026, an estimated $41.1K.
Immunovant made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1875 holding.
Prudential Financial first reported a position in Immunovant in Q4 2020 and has held it in 11 quarters since.
Prudential Financial's Immunovant position peaked at $2.56M in Q4 2023.
227 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.